Immediate versus deferred antiretroviral therapy in HIV-infected patients presenting with acute AIDS-defining events (toxoplasmosis, Pneumocystis jirovecii-pneumonia): a prospective, randomized, open-label multicenter study (IDEAL-study)

Schaefer, Guido; Hoffmann, Christian; Arasteh, Keikawus; Schuermann, Dirk; Stephan, Christoph; Jensen, Bjoern; Stoll, Matthias; Bogner, Johannes R.; Faetkenheuer, Gerd; Rockstroh, Juergen; Klinker, Hartwig; Haerter, Georg; Stoehr, Albrecht; Degen, Olaf; Freiwald, Eric; Huefner, Anja; Jordan, Sabine; Zur Wiesch, Julian Schulze; Addo, Marylyn; Lohse, Ansgar W.; van Lunzen, Jan; Schmiedel, Stefan; IDEAL Study Grp

Erstveröffentlichung

2019

Metadata only
Search for full text

Wissenschaftlicher Artikel

Authors

Schaefer, Guido

Hoffmann, Christian

Arasteh, Keikawus

Schuermann, Dirk

Stephan, Christoph

et al.

Institutions

UKU. Klinik für Innere Medizin III

Published in

AIDS Research and Therapy ; 16 (2019), 1. - Art.-Nr. 34. - ISSN 1742-6405

Link to publication

https://dx.doi.org/10.1186/s12981-019-0250-2

Funding information

Bristol-Myers-Squibb (BMS)Bristol-Myers Squibb

Keywords

Late presentation; Opportunistic infections; Pneumocystis jirovecii; PCP; Cerebral toxoplasmosis HIV; Diagnosis; Treatment; LATE DIAGNOSIS; INITIATION; START; CONSEQUENCES; INDIVIDUALS; COMBINATION; EFFICACY; EARLIER; SAFETY; TIME

Dewey Decimal Group

DDC 610 / Medicine & health

Metadata

Show full item record